Mass. biotechs leaping into generic drug market – Boston Globe

January 20, 2012 Posted By: Leave a comment
Biotechnology companies spent years lobbying against allowing ... in part because the manufacturing process is so complex and expensive. But under a 2010 law, the US Food and Drug Administration is developing a process by which they could ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>